Miller Mark A, Stabenow Jennifer M, Parvathareddy Jyothi, Wodowski Andrew J, Fabrizio Thomas P, Bina Xiaowen R, Zalduondo Lillian, Bina James E
The University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
PLoS One. 2012;7(2):e31359. doi: 10.1371/journal.pone.0031359. Epub 2012 Feb 24.
Intranasal instillation is a widely used procedure for pneumonic delivery of drugs, vaccine candidates, or infectious agents into the respiratory tract of research mice. However, there is a paucity of published literature describing the efficiency of this delivery technique. In this report we have used the murine model of tularemia, with Francisella tularensis live vaccine strain (FTLVS) infection, to evaluate the efficiency of pneumonic delivery via intranasal dosing performed either with differing instillation volumes or different types of anesthesia. FTLVS was rendered luminescent via transformation with a reporter plasmid that constitutively expressed the Photorhabdus luminescens lux operon from a Francisella promoter. We then used an IVIS Spectrum whole animal imaging system to visualize FT dissemination at various time points following intranasal instillation. We found that instillation of FT in a dose volume of 10 µl routinely resulted in infection of the upper airways but failed to initiate infection of the pulmonary compartment. Efficient delivery of FT into the lungs via intranasal instillation required a dose volume of 50 µl or more. These studies also demonstrated that intranasal instillation was significantly more efficient for pneumonic delivery of FTLVS in mice that had been anesthetized with inhaled (isoflurane) vs. parenteral (ketamine/xylazine) anesthesia. The collective results underscore the need for researchers to consider both the dose volume and the anesthesia type when either performing pneumonic delivery via intranasal instillation, or when comparing studies that employed this technique.
鼻内滴注是一种广泛应用的将药物、候选疫苗或感染因子经肺部递送至研究小鼠呼吸道的方法。然而,关于这种递送技术效率的已发表文献较少。在本报告中,我们使用了兔热病的小鼠模型,感染土拉弗朗西斯菌活疫苗株(FTLVS),以评估通过不同滴注体积或不同类型麻醉进行鼻内给药的肺部递送效率。通过用一个报告质粒转化使FTLVS发光,该报告质粒从弗朗西斯菌启动子组成型表达发光杆菌的lux操纵子。然后,我们使用IVIS Spectrum全动物成像系统在鼻内滴注后的各个时间点可视化FT的传播。我们发现,以10 μl的剂量体积滴注FT通常会导致上呼吸道感染,但未能引发肺腔感染。通过鼻内滴注将FT有效递送至肺部需要50 μl或更大的剂量体积。这些研究还表明,对于用吸入(异氟烷)麻醉而非肠胃外(氯胺酮/赛拉嗪)麻醉的小鼠,鼻内滴注对FTLVS进行肺部递送的效率显著更高。这些总体结果强调,研究人员在通过鼻内滴注进行肺部递送时,或在比较采用该技术的研究时,需要同时考虑剂量体积和麻醉类型。